PHASE-II TRIAL OF COMBINED 5-FLUOROURACIL PLUS DOXORUBICIN PLUS CISPLATIN (FAP REGIMEN) IN ADVANCED GASTRIC-CARCINOMA

被引：0
|
作者：
ROUGIER, P
DROZ, JP
THEODORE, C
PIOT, G
HERAIT, P
RUFFIE, P
CARDE, P
CVITKOVIC, E
机构：
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1301 / 1302
页数：2
相关论文
共 50 条
  • [31] CONTINUOUS 5-FLUOROURACIL INFUSION IN ADVANCED GASTRIC-CARCINOMA
    MOYNIHAN, T
    HANSEN, R
    ANDERSON, T
    QUEBBEMAN, E
    BEATTY, P
    AUSMAN, R
    RITCH, P
    CHITAMBAR, C
    VUKELICH, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 461 - 464
  • [32] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WOOLLEY, P
    SMITH, F
    ESTEVEZ, R
    GISSELBRECHT, C
    ALVAREZ, C
    BOIRON, M
    MACHADO, C
    LAGARDE, C
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 455 - 455
  • [33] INTERFERON COMBINED 5-FLUOROURACIL PLUS CISPLATIN HEPATIC ARTERIAL INFUSION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Yamashita, Tatsuya
    Arai, Kuniaki
    Sunagozaka, Hajime
    Ueda, Teruyuki
    Mizukoshi, Eishiro
    Sakai, Akito
    Nakamoto, Yasunari
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2009, 50 (04) : 1093A - 1093A
  • [34] Randomized, phase II study comparing interferon combined 5-fluorouracil plus cisplatin hepatic arterial infusion with interferon combined 5-fluorouracil hepatic arterial infusion in patients with advanced hepatocellular carcinoma
    Yamashita, T.
    Arai, K.
    Sunagozaka, H.
    Ueda, T.
    Terashima, T.
    Mizukoshi, E.
    Sakai, A.
    Nakamoto, Y.
    Honda, M.
    Kaneko, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol
    Chen, Yun
    Zhu, Zhengfei
    Zhao, Weixin
    Li, Ling
    Ye, Jinjun
    Wu, Chaoyang
    Tang, Huarong
    Lin, Qin
    Li, Jiancheng
    Xia, Yi
    Li, Yunhai
    Zhou, Jialiang
    Zhao, Kuaile
    RADIATION ONCOLOGY, 2018, 13
  • [36] COMBINATION CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL 5-DAY INFUSION IN THE THERAPY OF ADVANCED GASTRIC-CANCER - A PHASE-II TRIAL
    LACAVE, AJ
    BARON, FJ
    ANTON, LM
    ESTRADA, E
    DESANDE, LMG
    PALACIO, I
    ESTEBAN, E
    GRACIA, JM
    BUESA, JM
    FERNANDEZ, OA
    BARON, MG
    ANNALS OF ONCOLOGY, 1991, 2 (10) : 751 - 754
  • [37] 5-FLUOROURACIL, DOXORUBICIN, AND CISPLATIN REGIMEN IN ADRENAL-CORTICAL CARCINOMA
    SCHLUMBERGER, M
    OSTRONOFF, M
    BELLAICHE, M
    ROUGIER, P
    DROZ, JP
    PARMENTIER, C
    CANCER, 1988, 61 (08) : 1492 - 1494
  • [38] EFFICACY OF COMBINED 5-FLUOROURACIL AND CISPLATINUM IN ADVANCED GASTRIC CARCINOMAS - A PHASE-II TRIAL WITH PROGNOSTIC FACTOR-ANALYSIS
    ROUGIER, P
    DUCREUX, M
    MAHJOUBI, M
    PIGNON, JP
    BELLEFQIH, S
    OLIVEIRA, J
    BOGNEL, C
    LASSER, P
    YCHOU, M
    ELIAS, D
    CVITKOVIC, E
    ARMAND, JP
    DROZ, JP
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1263 - 1269
  • [39] CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY IN ADVANCED AND OR METASTATIC COLORECTAL-CARCINOMA - A PHASE-II STUDY
    GALLIGIONI, E
    CANOBBIO, L
    FIGOLI, F
    FASSIO, T
    FRUSTACI, S
    CRIVELLARI, D
    VACCHER, E
    RE, GL
    GASPARINI, G
    VERONESI, A
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 657 - 661
  • [40] A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma
    Zhu, Yujia
    Zhang, Wenwen
    Li, Qiaoqiao
    Li, Qiwen
    Qiu, Bo
    Liu, Hui
    Liu, Mengzhong
    Hu, Yonghong
    JOURNAL OF CANCER, 2017, 8 (18): : 3657 - 3666
12345